Inogen, Inc. (INGN)
Inogen, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Beverly, MA, US. The stock last traded at $5.85, down 0.85% on the session, giving a market capitalisation of $158.4M. On trailing twelve-month figures it carries a trailing P/E of -6.50, a net margin of -6.9%. Its beta of 1.59 implies it has historically moved more than the broad market.
Inogen, Inc. operates as a medical technology enterprise dedicated to designing, fabricating, and distributing oxygen concentration equipment. These cutting-edge devices are engineered to provide continuous oxygen support for patients managing persistent respiratory conditions. The company's diverse product range features the popular portable Inogen One, which efficiently draws oxygen from the surrounding atmosphere to offer an independent supply, alongside stationary Inogen At Home concentrators, Tidal Assist Ventilators, and various associated accessories. Inogen serves a broad clientele, including individual patients, medical professionals, and insurance providers, both domestically in the United States and globally. Furthermore, the company facilitates direct equipment rentals to patients. Founded in 2001, Inogen, Inc. is headquartered in Goleta, California.
Inogen, Inc. is most often compared with the following Healthcare names: